Challenges in CAR-T therapy resistance and the role of bispecific antibodies

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in chronic lymphocytic leukemia (CLL), lymphoma, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and more.

In this podcast, you will hear from Loretta Nastoupil, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, Tycel Phillips, MD, City of Hope, Duarte, CA, and Mazyar Shadman, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, who share some updates on CAR-T therapy in lymphoma, and further discuss where bispecific antibodies may fit in the treatment landscape.

The post iwCAR-T Session I: CAR-T therapy in lymphoma and the role of bispecific antibodies appeared first on VJHemOnc.